Geneve Allison
Overview
Explore the profile of Geneve Allison including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peters E, Albalawi Z, van Asten S, Abbas Z, Allison G, Aragon-Sanchez J, et al.
Diabetes Metab Res Rev
. 2023 Oct;
40(3):e3730.
PMID: 37814825
The optimal approaches to managing diabetic foot infections remain a challenge for clinicians. Despite an exponential rise in publications investigating different treatment strategies, the various agents studied generally produce comparable...
2.
Senneville E, Albalawi Z, van Asten S, Abbas Z, Allison G, Aragon-Sanchez J, et al.
Clin Infect Dis
. 2023 Oct;
PMID: 37779457
The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines on the management and prevention of diabetes-related foot diseases since 1999. The present guideline is an update...
3.
Senneville E, Albalawi Z, van Asten S, Abbas Z, Allison G, Aragon-Sanchez J, et al.
Diabetes Metab Res Rev
. 2023 Oct;
40(3):e3687.
PMID: 37779323
The International Working Group on the Diabetic Foot (IWGDF) has published evidence-based guidelines on the management and prevention of diabetes-related foot diseases since 1999. The present guideline is an update...
4.
Senneville E, Albalawi Z, van Asten S, Abbas Z, Allison G, Aragon-Sanchez J, et al.
Diabetes Metab Res Rev
. 2023 Sep;
40(3):e3723.
PMID: 37715722
Background: Securing an early accurate diagnosis of diabetic foot infections and assessment of their severity are of paramount importance since these infections can cause great morbidity and potential mortality and...
5.
Shah A, Petrak R, Fliegelman R, Shrestha N, Allison G, Zurlo J, et al.
Clin Infect Dis
. 2018 Sep;
68(7):1160-1165.
PMID: 30247512
Background: Outpatient parenteral antimicrobial therapy (OPAT) can be managed by specialists in infectious diseases (ID) or by other physicians. Better management of OPAT can reduce the likelihood of readmission or...
6.
Ajjampur S, Sarkar R, Allison G, Banda K, Kane A, Muliyil J, et al.
Clin Vaccine Immunol
. 2011 Feb;
18(4):633-9.
PMID: 21288997
The surface-associated glycopeptides gp40, one of the most polymorphic Cryptosporidium antigens, and gp15, one of the most immunodominant Cryptosporidium antigens, are putative vaccine candidates because they mediate infection in vitro...
7.
Wanyiri J, OConnor R, Allison G, Kim K, Kane A, Qiu J, et al.
Infect Immun
. 2006 Oct;
75(1):184-92.
PMID: 17043102
The apicomplexan parasite Cryptosporidium causes diarrheal disease worldwide. Proteolytic processing of proteins plays a significant role in host cell invasion by apicomplexan parasites. In previous studies, we described gp40/15, a...
8.
Swift M, Altman D, Allison G, Iton A, Kears D, Rose T, et al.
Surgery
. 2006 Apr;
139(4):466-8.
PMID: 16627055
No abstract available.
9.
Successful use of a polymerized hemoglobin blood substitute in a critically anemic Jehovah's Witness
Allison G, Feeney C
South Med J
. 2005 Jan;
97(12):1257-8.
PMID: 15646766
A stable, polymerized hemoglobin product has been formulated that overcomes the three traditional hurdles of hemoglobin-based blood substitutes: nephrotoxicity, osmotic diuresis, and blood-borne pathogens. We present a case of a...